Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biotin-Labeled RBC Survival Validation
NCT02757898Phase 1Completed
- Sponsor
- Emory University
- Start
- Jan 2017
- Primary completion
- Nov 2018
- Modality
- Recombinant Proteins and Enzymes, Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Biotinylated red blood cell in anemia, sponsored by Emory University. Primary endpoints: Number of Participants That Had bRBC Detectable at 70 Days Post-intervention and Length of Time Differentially Labeled Biotin-labeled RBCs Can be Distinguished From One Another up to 112 days. Started Jan 2017; status: completed.
02
Drugs
Biotinylated red blood cell
03
Conditions
anemia
Beyond the preview
Go deeper on NCT02757898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02757898.